Symposium - Oxford, United Kingdom
Aptamers are a new class of molecules with a great potential to rival monoclonal antibodies in therapeutic, diagnostic, analytical as well as basic research applications. Described just over two decades ago, there has been an ever growing interest in these molecules as evidenced by the considerable increase in the number of related publications. Furthermore, the field of aptamer technology received a great boost in 2004 after the first FDA approved drug, Macugen, to treat age related macular degeneration, and later the development of the first aptamer based diagnostic platform for the analysis of mycotoxins in grain. In subsequent years there has been an outstanding growth in the Aptamer based companies and the range of developed products.
This symposium is one of the first international meetings at Oxford that will bring together the aptamer community from both academia and industry. This event would form the foundations for an annual gathering that would witness the aptamer technology coming out of age.
Organization: LPMHealthcare
(Oxford skyline panorama, photo mountage via en.wikipedia.org)
Mon, Mar 24, 2014 - Tue, Mar 25, 2014
St Edmund's Hall
Queen's Street, Oxford, United Kingdom
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.